Beck Mack & Oliver LLC Amgen Inc Transaction History

Beck Mack & Oliver LLC

$4.44 Billion
Q3 2024

A detailed history of Beck Mack & Oliver LLC transactions in Amgen Inc stock. As of the latest transaction made, Beck Mack & Oliver LLC holds 4,589 shares of AMGN stock, worth $1.28 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,589

Previous 4,569 0.44%

Holding current value

$1.28 Million

Previous $1.43 Million 3.57%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $6,187 - $6,747	20 Added 0.44%	4,589 $1.48 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $262 - $319	1 Added 0.02%	4,569 $1.43 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $23,929 - $28,885	89 Added 1.99%	4,568 $1.3 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $1.15 Million - $1.29 Million	4,479 New	4,479 $1.29 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $968,982 - $1.08 Million	-4,200 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $1,698 - $1,989	-8 Reduced 0.19%	4,200 $893,000
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $1,868 - $2,073	8 Added 0.19%	4,208 $1.03 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $221,910 - $258,600	-1,000 Reduced 19.23%	4,200 $1.05 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $32,803 - $43,506	-180 Reduced 3.35%	5,200 $1.05 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $3,482 - $4,172	-20 Reduced 0.37%	5,380 $1.04 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $142,720 - $166,600	-800 Reduced 12.9%	5,400 $1.05 Million
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $1.04 Million - $1.18 Million	6,200	6,200 $0

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.

Account

Beck Mack & Oliver LLC Amgen Inc Transaction History